Acrigen Biosciences Raises Seed Financing to Advance Precision Gene Editing Technology and Therapeutic Pipeline

BERKELEY, Calif.--(BUSINESS WIRE)--Acrigen Biosciences announces seed financing led by Red Tree Venture Capital.

Click to view original post